DABIGATRAN ETEXILATE 150 MG CP

Dabigatran Etexilate
$0.8705per EA
Low Outlier

Strength

150 mg/1

NDC

00378026691

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Last Updated

4/22/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA208067

On Market Since

2/25/2025

Pharmacological Classes

Direct Thrombin Inhibitor
Thrombin Inhibitors

Price History

1W

0.0%

1M

-1.4%

3M

-3.4%

6M

-20.1%

1Y

-45.0%

3Y

N/A

5Y

N/A

All

-47.2%